- Home
- DAWN vs RXO Comparison
DAWN vs RXO Comparison
Compare DAWN & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DAWN | RXO |
|---|---|---|
| Founded | 2018 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DAWN | RXO |
|---|---|---|
| Price | $21.50 | $24.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $24.43 | $16.33 |
| AVG Volume (30 Days) | 2.7M | ★ 3.0M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.81 |
| EPS | N/A | ★ N/A |
| Revenue | $158,182,000.00 | ★ $5,742,000,000.00 |
| Revenue This Year | $55.03 | $0.49 |
| Revenue Next Year | $28.12 | $6.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 20.60 | ★ 26.20 |
| 52 Week Low | $5.64 | $10.43 |
| 52 Week High | $21.53 | $25.03 |
Technical Indicators
Market Signals| Indicator | DAWN | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 80.29 | 68.68 |
| Support Level | $10.30 | $15.46 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.03 | 1.71 |
| MACD | -0.28 | 0.42 |
| Stochastic Oscillator | 90.91 | 95.86 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.